NVAX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Novavax (NVAX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NVAX is expected to report earnings to fall 21.58% to -59 cents per share on March 04

Q4'24

Est.

$-0.60

Q3'24

Beat

by $0.07

Q2'24

Missed

by $0.68

Q1'24

Missed

by $0.13

Q4'23

Missed

by $0.99

The last earnings report on November 12 showed earnings per share of -75 cents, beating the estimate of -82 cents. With 756.07K shares outstanding, the current market capitalization sits at 1.44B.

View a ticker or compare two or three

Compare

NVAX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NVAX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NVAX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a company which engages in development of novel recombinant vaccines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

700 Quince Orchard Road

Phone

+1 240 268-2000

Employees

1534

Web

https://www.novavax.com